The expected CAGR of the global apixaban market tends to be around 5.70% in the mentioned forecast period. The market was valued at USD 1,765.8 million in 2022 and would grow to USD 2,908.17 million by 2030.
Apixaban is an oral anticoagulant medication that belongs to the class of direct oral anticoagulants (DOACs). It is primarily used for the prevention and treatment of blood clots, including deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke in patients with atrial fibrillation.
The market for apixaban has been significant due to its effectiveness, convenience (as it is administered orally), and favorable safety profile compared to traditional anticoagulants like warfarin. Apixaban is marketed under various brand names, including Eliquis (developed by Bristol-Myers Squibb and Pfizer) and Appaxaban (developed by Aspen Pharmacare).
Eliquis (apixaban) has been one of the leading drugs in the market for oral anticoagulants. It has gained substantial popularity and market share since its approval by regulatory authorities. In recent years, the market for apixaban and other DOACs has grown rapidly, largely due to their improved safety and convenience compared to older anticoagulant options.
A blood clot that forms inside a vein can be treated with apixaban, an anticoagulant that has been licenced by the Food and Drug Administration (FDA). Venous thromboembolic events (VTE) can happen suddenly and without any prior symptoms or warning signals, making them difficult for healthcare professionals to recognise and diagnose. The signs and symptoms that do manifest may be related to either deep vein thrombosis (DVT) or pulmonary embolism (PE), including chest pain, rapid breathing, swelling in the ankle or foot, calf, redness, or obvious discoloured areas. In addition, factor Xa, a serine protease with trypsin-like properties, is crucial to the blood coagulation cascade. Apixaban reduces the production of clots by working on the factor Xa inhibitory pathway.
Get Free Exclusive PDF Sample Copy of This Research Report https://stringentdatalytics.com/sample-request/apixaban-market/3275/
Market Segmentations:
Global Apixaban Market: By Company
• Pfizer
• Medichem
• Polpharma
• Beijing Cooperate Pharmaceutical
• Centaur Pharmaceutical
• DEAFARMA
• Dipharma Francis
Global Apixaban Market: By Type
• Capsule Apixaban
• Tablet Apixaban
Segment by Sale Channel
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
Global Apixaban Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Apixaban market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
Reasons to Purchase this Market Report:
- The competitive environment includes the proportions of important players, recent innovations, and strategy.
- Companies with extensive product offerings, pertinent financial data, recent advancements, SWOT analyses, and player tactics.
- Quantitative, qualitative, value (in USD million), and volume (in units million) data are among the segments and sub-segments.
- The research contains a wealth of data, including market dynamics and opportunities throughout the forecast period.
- Data at the regional, sub-regional, and national levels also provides information on the market’s supply and demand dynamics.
Access Full Report Here https://stringentdatalytics.com/reports/apixaban-market/3275/
Questions Answered in the Apixaban Market Report
- Which are the leading market players active in the apixaban market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What future projections would help in taking further strategic steps?
- What is apixaban market?
- What is apixaban market prediction in the future?
- Who are the leading global players in the apixaban market?
- What are the current trends and predicted trends?
- What are the key benefits of the apixaban market report?
About Stringent Datalytics
Stringent Datalytics offers both custom and syndicated market research reports. Custom market research reports are tailored to a specific client’s needs and requirements. These reports provide unique insights into a particular industry or market segment and can help businesses make informed decisions about their strategies and operations.
Syndicated market research reports, on the other hand, are pre-existing reports that are available for purchase by multiple clients. These reports are often produced on a regular basis, such as annually or quarterly, and cover a broad range of industries and market segments. Syndicated reports provide clients with insights into industry trends, market sizes, and competitive landscapes. By offering both custom and syndicated reports, Stringent Datalytics can provide clients with a range of market research solutions that can be customized to their specific needs.
Contact Us
Stringent Datalytics
Contact No- +1 346 666 6655
Email Id- sales@stringentdatalytics.com
